Published in Cancer Weekly, September 12th, 2006
Scientists in Poland conducted a study "to investigate the immunocytochemical expression of vascular endothelial growth factor C (VEGF-C) and its receptors (VEGFR-2 and VEGFR-3) in childhood ALL blasts and to determine the possible role of this complex in the pathogenesis and prognosis of ALL. Bone marrow samples were taken from 120 children diagnosed with ALL."
"An indirect immunocytochemical procedure was performed with the use of monoclonal mouse anti-human antibodies against VEGF-C, VEGFR-2 and VEGFR-3 (diluted 1:100). The immunocytochemical expression...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.